Letters, Testimony & Comments

February 11, 2008
Re: Special 301: Identification of Countries Under Section 182 of the Trade Act of 1974: Request for Public Comment, 73 Fed. Reg. 2958 (January 16, 2008). Dear Ms. Groves: The Biotechnology Industry Organization (BIO) is submitting this letter...
February 11, 2008
Office of the U.S. Trade Representative
February 8, 2008
BIO's comments on the World Medical Association's (WMA's) Declaration of Helsinki.
January 30, 2008
Re: Comments on Draft CY 2009 Call Letter Dear Dr. Tudor: The Biotechnology Industry Organization (BIO) appreciates this opportunity to comment on the Centers for Medicare & Medicaid Services’ (CMS) Draft 2009 Medicare Advantage (MA),...
January 28, 2008
Re: CMS-1392-FC (Medicare Program; Changes to the Hospital Outpatient Prospective Payment System and CY 2008 Payment Rates) Dear Administrator Weems: The Biotechnology Industry Organization (BIO) is pleased to submit the following comments on...
January 22, 2008
ACCESS AND BENEFIT-SHARING: PEER REVIEW PROCESS FOR ABS STUDIES COMMENTS OF THE BIOTECHNOLOGY INDUSTRY ORGANIZATION The Biotechnology Industry Organization (BIO) would like to express its appreciation to the Secretariat for making the...
January 10, 2008
Re: CMS–10224 (Agency Information Collection Activities: Proposed Collection; Comment Request; HCPCS Level II Code Modification Request Process) Dear Ms. Lovett: The Biotechnology Industry Organization (BIO) appreciates this opportunity...
January 1, 2008
BIO commends the IGWG for its work on a global strategy and plan of action that, according to its mandate, will aim at "securing an enhanced and sustainable basis for needs-driven, essential health R&D relevant to diseases that...
December 21, 2007
Re: CMS-2238-P (Medicaid Program; Prescription Drugs) Dear Acting Administrator Weems: The Biotechnology Industry Organization (BIO) appreciates this opportunity to comment on the Centers for Medicare and Medicaid Services’ (CMS) Final...
December 10, 2007
BIO's comments on proposed changes to the 2010 HCPCS Level II Modification Process